spacer
home > white papers > Clinical Trials in Russia Orange Paper: Summary of Year 2013 - Synergy Research Group
WHITE PAPERS
logo_Synergy_Re.JPG

Synergy Research Group

phone +7 495 600 4445
email request@synrg-pharm.com
web http://www.synrg-pharm.com
email 11, 4-Magistralnaya Ul., 123007 Moscow, Russia

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials.
Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
Clinical Trials in Russia Orange Paper: Summary of Year 2013
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

DoKaSch to provide cooling containers for El Al for pharma transport

El Al Israel Airlines has signed a master rental agreement with DoKaSch Temperature Solutions for the usage of ‘Opticooler’ containers. The airline will benefit from the active cooling container for its pharmaceutical shipments to and from Israel, DoKaSch said, being able to safely transport temperature-sensitive products to and from its headquarters at Ben Gurion Airport in the belly of its passenger fleet as well as a dedicated cargo aircraft.
More info >>


White Papers

Quality Systems Guide

Research Quality Association

This guide concentrates on the core, underlying principles of quality that are pivotal – explicitly or implicitly – to all quality management standards that impact on research and development.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement